Ron Peters in conversation with Ulf Landmesser
RESPONSE: Effect of a nurse coordinated prevention program on cardiovascular risk after an acute coronary syndrome: Main results of the RESPONSE trial.

Andreas Goette In conversation with Bernard Gersh
ANTIPAF: Angiotensin II-antagonist in paroxysmal atrial fibrillation trial.